Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients

Cinar O., Cevik E., Acar A., Kaya C., Ardic S., Comert B., ...More

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.30, no.9, pp.1915-1920, 2012 (SCI-Expanded) identifier identifier identifier


Objective: The aim of this study was to evaluate the diagnostic and the prognostic value of a laboratory panel consisting of mid-regional pro-atrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and mid-regional pro-adrenomedullin (MR-proADM) for patients presenting to the emergency department (ED) with acute dyspnea.